FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308289859> ?p ?o ?g. }

• W4308289859 endingPage "506" @default.
• W4308289859 startingPage "497" @default.
• W4308289859 abstract "Great efforts have been made to manipulate nanoparticles (NPs) with a diameter of 10-100 nm to passively target lymph nodes (LNs) to magnitude anti-tumor activity of T cells. However, no attention has been paid to increasing the retention of NPs with active affinity in order to induce a prolonged release of antigens or molecular adjuvants in the LNs mattering the immune response. Here, we formulated two NPs encapsulated with imiquimod (IMQ), a TLR7/8 agonist, and paclitaxel (PTX) and further modified them with tannic acid (TA), respectively, to generate IMQ NP and PTX NP with a final diameter of approximately 40 nm. Attributing a strong affinity of TA molecules to the elastin of LN conduits, the TA modified IMQ NPs can bypass the gaps in the layer of lymphatic endothelial cells and enter the paracortex through the lymph node capsule-associated (LNC) conduits. Similarly, the TA modified PTX NPs increased delivery of PTX to the metastatic tumor site in LNs, where the tumor-associated antigens were released and presented by conduits-lining dendritic cells to activate T cells. Thus, the NPs with deposition to LN conduits showed excellent performance in preventing lymphovascular invasion of triple-negative breast cancer cells and lung metastasis thereafter. On the contrary, the NPs without TA flowed through the subcutaneous sinus existing LNs directly by efferent lymphatic vessels showing relatively poor therapeutic outcomes. This study reveals that TA may mediate the long retention of antigens and molecular adjuvants to be delivered to deep LNs for developing potent vaccination technology." @default.
• W4308289859 created "2022-11-10" @default.
• W4308289859 creator A5019552597 @default.
• W4308289859 creator A5047145848 @default.
• W4308289859 creator A5051229707 @default.
• W4308289859 creator A5062112321 @default.
• W4308289859 creator A5074103625 @default.
• W4308289859 creator A5077613732 @default.
• W4308289859 creator A5081571888 @default.
• W4308289859 creator A5083733116 @default.
• W4308289859 date "2022-12-01" @default.
• W4308289859 modified "2023-10-12" @default.
• W4308289859 title "Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels" @default.
• W4308289859 cites W2009291926 @default.
• W4308289859 cites W2054196270 @default.
• W4308289859 cites W2067954786 @default.
• W4308289859 cites W2078039120 @default.
• W4308289859 cites W2102284924 @default.
• W4308289859 cites W2114780139 @default.
• W4308289859 cites W2124152040 @default.
• W4308289859 cites W2142804430 @default.
• W4308289859 cites W2145174078 @default.
• W4308289859 cites W2338495285 @default.
• W4308289859 cites W2791572126 @default.
• W4308289859 cites W2795115855 @default.
• W4308289859 cites W2799529459 @default.
• W4308289859 cites W2802211855 @default.
• W4308289859 cites W2811457913 @default.
• W4308289859 cites W2838505861 @default.
• W4308289859 cites W2911310494 @default.
• W4308289859 cites W2912993657 @default.
• W4308289859 cites W2921614854 @default.
• W4308289859 cites W2942697286 @default.
• W4308289859 cites W2969257935 @default.
• W4308289859 cites W2990280215 @default.
• W4308289859 cites W3003307197 @default.
• W4308289859 cites W3006851308 @default.
• W4308289859 cites W3010692114 @default.
• W4308289859 cites W3012821758 @default.
• W4308289859 cites W3013544658 @default.
• W4308289859 cites W3033020580 @default.
• W4308289859 cites W3034131806 @default.
• W4308289859 cites W3091948925 @default.
• W4308289859 cites W3092374205 @default.
• W4308289859 cites W3137080911 @default.
• W4308289859 cites W3164029425 @default.
• W4308289859 cites W3204809286 @default.
• W4308289859 cites W3207153364 @default.
• W4308289859 cites W4206186185 @default.
• W4308289859 cites W4220735688 @default.
• W4308289859 cites W4229376032 @default.
• W4308289859 cites W4377261262 @default.
• W4308289859 doi "https://doi.org/10.1016/j.jconrel.2022.10.053" @default.
• W4308289859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36341931" @default.
• W4308289859 hasPublicationYear "2022" @default.
• W4308289859 type Work @default.
• W4308289859 citedByCount "4" @default.
• W4308289859 countsByYear W43082898592023 @default.
• W4308289859 crossrefType "journal-article" @default.
• W4308289859 hasAuthorship W4308289859A5019552597 @default.
• W4308289859 hasAuthorship W4308289859A5047145848 @default.
• W4308289859 hasAuthorship W4308289859A5051229707 @default.
• W4308289859 hasAuthorship W4308289859A5062112321 @default.
• W4308289859 hasAuthorship W4308289859A5074103625 @default.
• W4308289859 hasAuthorship W4308289859A5077613732 @default.
• W4308289859 hasAuthorship W4308289859A5081571888 @default.
• W4308289859 hasAuthorship W4308289859A5083733116 @default.
• W4308289859 hasConcept C121608353 @default.
• W4308289859 hasConcept C126322002 @default.
• W4308289859 hasConcept C142724271 @default.
• W4308289859 hasConcept C147483822 @default.
• W4308289859 hasConcept C181152851 @default.
• W4308289859 hasConcept C185592680 @default.
• W4308289859 hasConcept C203014093 @default.
• W4308289859 hasConcept C2777292972 @default.
• W4308289859 hasConcept C2778740770 @default.
• W4308289859 hasConcept C2779013556 @default.
• W4308289859 hasConcept C2779112978 @default.
• W4308289859 hasConcept C2779720271 @default.
• W4308289859 hasConcept C2780849966 @default.
• W4308289859 hasConcept C502942594 @default.
• W4308289859 hasConcept C71924100 @default.
• W4308289859 hasConcept C8891405 @default.
• W4308289859 hasConceptScore W4308289859C121608353 @default.
• W4308289859 hasConceptScore W4308289859C126322002 @default.
• W4308289859 hasConceptScore W4308289859C142724271 @default.
• W4308289859 hasConceptScore W4308289859C147483822 @default.
• W4308289859 hasConceptScore W4308289859C181152851 @default.
• W4308289859 hasConceptScore W4308289859C185592680 @default.
• W4308289859 hasConceptScore W4308289859C203014093 @default.
• W4308289859 hasConceptScore W4308289859C2777292972 @default.
• W4308289859 hasConceptScore W4308289859C2778740770 @default.
• W4308289859 hasConceptScore W4308289859C2779013556 @default.
• W4308289859 hasConceptScore W4308289859C2779112978 @default.
• W4308289859 hasConceptScore W4308289859C2779720271 @default.
• W4308289859 hasConceptScore W4308289859C2780849966 @default.
• W4308289859 hasConceptScore W4308289859C502942594 @default.
• W4308289859 hasConceptScore W4308289859C71924100 @default.

• next